Immune-Induced Epithelial to Mesenchymal Transition <i>In vivo</i> Generates Breast Cancer Stem CellsMarta Santisteban, Keith L. Knutson|Cancer Research|2009Cited by 378
Tumor-Infiltrating Programmed Death Receptor-1+ Dendritic Cells Mediate Immune Suppression in Ovarian CancerJames Krempski, Keith L. Knutson|The Journal of Immunology|2011Cited by 241
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trialDaniel V.T. Catenacci, Yung‐Jue Bang, Yoon‐Koo Kang et al.|The Lancet Oncology|2020Cited by 190
Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer PatientsKimberly R. Kalli, Keith L. Knutson, G. Haswell Wilson et al.|Clinical Cancer Research|2018Cited by 97
Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockadeYan Luo, Keith L. Knutson|Journal for ImmunoTherapy of Cancer|2023Cited by 23